Steve Mertens Neuroone Medical Technologies Corp (NMTC) insider trading activity

Steve Mertens is Chief Technology Officer of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 173,085 shares of NMTC, which is worth approximately $107,312. The most recent transaction as insider was on Oct 31, 2024, when has been sold 252 shares (Common Stock) at a price of $0.97 per share, resulting in proceeds of $244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 173K

0.95% 3M change

107.47% 12M change

Total Value Held $107,312

Steve Mertens Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2024	SELL Payment of exercise price or tax liability	$244 $0.97 p/Share	252 Reduced 0.15%	173,085 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$1,146 $0.99 p/Share	1,158 Reduced 0.66%	173,337 Common Stock
Aug 31 2024	SELL Payment of exercise price or tax liability	$201 $0.8 p/Share	252 Reduced 0.14%	174,495 Common Stock
Jul 31 2024	SELL Payment of exercise price or tax liability	$189 $0.75 p/Share	252 Reduced 0.14%	174,747 Common Stock
Jun 30 2024	SELL Payment of exercise price or tax liability	$926 $0.8 p/Share	1,158 Reduced 0.66%	174,999 Common Stock
May 31 2024	SELL Payment of exercise price or tax liability	$234 $0.93 p/Share	252 Reduced 0.14%	176,157 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$284 $1.13 p/Share	252 Reduced 0.14%	176,409 Common Stock
Apr 21 2024	SELL Payment of exercise price or tax liability	$8,337 $1.15 p/Share	7,250 Reduced 3.94%	176,661 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$302 $1.2 p/Share	252 Reduced 0.14%	183,911 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$304 $1.21 p/Share	252 Reduced 0.14%	184,163 Common Stock
Feb 18 2024	BUY Grant, award, or other acquisition	-	101,743 Added 35.55%	184,415 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$315 $1.25 p/Share	252 Reduced 0.3%	82,672 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$398 $1.58 p/Share	252 Reduced 0.3%	82,924 Common Stock
Nov 30 2023	SELL Payment of exercise price or tax liability	$365 $1.45 p/Share	252 Reduced 0.3%	83,176 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	$405 $1.61 p/Share	252 Reduced 0.3%	83,428 Common Stock
Oct 31 2023	SELL Payment of exercise price or tax liability	$226 $0.9 p/Share	252 Reduced 0.3%	83,680 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$224 $0.89 p/Share	252 Reduced 0.3%	83,932 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$214 $0.85 p/Share	252 Reduced 0.3%	84,184 Common Stock
Jul 31 2023	SELL Payment of exercise price or tax liability	$257 $1.02 p/Share	252 Reduced 0.3%	84,436 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$302 $1.2 p/Share	252 Reduced 0.3%	84,688 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$304 $1.21 p/Share	252 Reduced 0.3%	84,940 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$388 $1.54 p/Share	252 Reduced 0.29%	85,192 Common Stock
Apr 21 2023	BUY Grant, award, or other acquisition	-	50,000 Added 36.92%	85,444 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$405 $1.61 p/Share	252 Reduced 0.71%	35,444 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$8,899 $1.47 p/Share	6,054 Reduced 14.5%	35,696 Common Stock

Steve Mertens

Chief Technology Officer

Eden Prairie, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Value

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC

Account